About this trial
The pathophysiology of primary immunodeficiencies (PID), which encompass a broad range of different diseases with susceptibility to infection and/or a deregulated inflammatory response, is poorly understood. Available treatments are often not specific for a distinct target and might be associated with side effects. To elucidate pathophysiology of different PIDs, stool, urine, blood, tissue biopsies and/or bone marrow will be collected and analysed for anti-microbial activity and inflammatory response. In a second step, targeted treatment for different PIDs might be developed preclinically and ex vivo according to underlying pathophysiology.
Eligibility criteria
Qualifiers
Clinical diagnosis of an inborn error of immunity (primary immunodeficiency, PID)
Clinically healthy (non-age matched) volunteer
Disqualifiers
exclusion of an inborn error of immunity
secondary immunodeficiency
refusal to enter the study
Trial design
Treatments tested in this trial
- Diagnostic Test